Literature DB >> 20417802

Peginterferon alpha-2b and acute allograft failure in a heart transplant recipient.

Bing-Yen Wang1, Hsiao-Huang Chang, I-Ming Chen, Chun-Che Shih, An-Hang Yang.   

Abstract

Reports of heart transplant recipients with hepatitis C viral infection treated with peginterferon alpha-2b and ribavirin are very rare. We report a fatal case of acute allograft failure and hepatitis C viral infection in a 50-year-old orthotopic heart transplant recipient. At autopsy, the patient was found to have patent coronary arteries, diffuse severe fatty degeneration of heart myocytes, and no evidence of cellular or humoral rejection, confirming this as a fatal case of cardiotoxicity from peginterferon alpha-2b. Copyright (c) 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20417802     DOI： 10.1016/j.athoracsur.2009.09.084

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  8 in total

1.  Accepting Hearts From Hepatitis C-Positive Donor: Can We Expand the Donor Pool?

Authors:  Jonathan Grinstein; Laura M Lourenco; Helen S Te; John F Renz; Valluvan Jeevanandam; Nir Uriel
Journal:  J Card Fail       Date:  2017-06-13       Impact factor: 5.712

Review 2.  A concise review of hepatitis C in heart and lung transplantation.

Authors:  Edward Yc Kim; Hin Hin Ko; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2011-08       Impact factor: 3.522

3.  Donor selection in the modern era.

Authors:  Kiran K Khush
Journal:  Ann Cardiothorac Surg       Date:  2018-01

Review 4.  New Approaches to Donor Selection and Preparation in Heart Transplantation.

Authors:  Calvin K W Tong; Kiran K Khush
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-03-23

Review 5.  Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon.

Authors:  Sara Belga; Karen Elizabeth Doucette
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 6.  Treatment of hepatitis C virus infection and associated vascular complications: a literature review.

Authors:  Reza Karbasi-Afshar
Journal:  Iran J Med Sci       Date:  2014-05

Review 7.  Side effects of cytokines approved for therapy.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

Review 8.  Should we consider patients with coexistent hepatitis B or C infection for orthotopic heart transplantation?

Authors:  Baskar Sekar; Pippa J Newton; Simon G Williams; Steven M Shaw
Journal:  J Transplant       Date:  2013-11-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.